Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
City of Livonia Employees' Retirement System v. Essner et al
Case Number:
1:07-cv-10329
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
August 08, 2013
Wyeth To Pay $14M In Attys' Fees In Pristiq Class Action
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. will pay $13.5 million in attorneys' fees for a drug-related class action settlement after a New York federal judge on Wednesday ruled that the stockholder who objected to the payout lacked standing.
-
November 13, 2012
Pfizer Pays $67.5M To End Investors' Pristiq Disclosure Row
Pfizer Inc. unit Wyeth Pharmaceuticals Inc. agreed Friday to pay $67.5 million to settle a class action in New York federal court brought by a group of investors who say the company failed to disclose serious side effects associated with the antidepressant Pristiq.
-
September 18, 2012
Wyeth Investors Win Class Cert. In Suit Over Pristiq Risks
A New York federal judge on Tuesday granted class certification to a group of investors accusing Pfizer Inc. unit Wyeth Pharmaceuticals Inc. of failing to disclose serious side effects associated with the antidepressant Pristiq.
-
May 10, 2012
Wyeth Investors Likely To Win Class Cert. In Pristiq Case
A New York federal judge on Thursday said he will likely grant class certification to a group of investors who claim Pfizer Inc. unit Wyeth Pharmaceuticals Inc. did not disclose serious side effects associated with the antidepressant Pristiq.
-
October 21, 2011
Wyeth Shareholders Seek Class Cert. In Pristiq Suit
A Massachusetts pension fund asked a New York federal court Friday to certify a class of investors who claim that Pfizer Inc. unit Wyeth Pharmaceuticals Inc. obscured possibly serious side effects of its menopause and depression drug Pristiq in public announcements.